Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1095) 1095
Publication (57) 57
Conference Proceeding (44) 44
Book Review (25) 25
Book Chapter (21) 21
Book / eBook (8) 8
Dissertation (5) 5
Patent (5) 5
Newspaper Article (2) 2
Magazine Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (289) 289
female (251) 251
oncology (156) 156
index medicus (144) 144
middle aged (125) 125
adult (116) 116
aged (104) 104
breast cancer (97) 97
prognosis (91) 91
male (86) 86
breast neoplasms - pathology (83) 83
analysis (63) 63
animals (61) 61
breast neoplasms - drug therapy (53) 53
cancer (53) 53
aged, 80 and over (51) 51
chemotherapy (44) 44
medicine & public health (44) 44
obstetrics & gynecology (44) 44
breast neoplasms - mortality (41) 41
immunohistochemistry (40) 40
research (38) 38
metastasis (36) 36
carcinoma (34) 34
breast neoplasms - metabolism (33) 33
disease-free survival (31) 31
therapy (31) 31
apoptosis (30) 30
care and treatment (30) 30
expression (30) 30
survival (30) 30
treatment outcome (30) 30
neoplasm staging (29) 29
risk factors (29) 29
antineoplastic combined chemotherapy protocols - therapeutic use (27) 27
chemotherapy, adjuvant (27) 27
biochemistry & molecular biology (26) 26
cell biology (26) 26
child (26) 26
time factors (26) 26
adolescent (25) 25
lymphatic metastasis (25) 25
survival rate (25) 25
urokinase-type plasminogen activator - analysis (25) 25
children (24) 24
hematology (24) 24
prospective studies (24) 24
behavioral sciences (23) 23
breast neoplasms - genetics (23) 23
genetics & heredity (23) 23
management (23) 23
neoplasm metastasis (23) 23
obesity (23) 23
pai-1 (22) 22
plasminogen activator inhibitor 1 - analysis (22) 22
tumors (22) 22
urokinase-type plasminogen activator - metabolism (21) 21
biomarkers, tumor - analysis (20) 20
gene expression (20) 20
research article (20) 20
studies (20) 20
tamoxifen (20) 20
breast-cancer (19) 19
cohort studies (19) 19
evolutionary biology (19) 19
proteins (19) 19
cell line, tumor (18) 18
growth (18) 18
health aspects (18) 18
multivariate analysis (18) 18
upa (18) 18
ecology (17) 17
invasion (17) 17
neoplasm invasiveness (17) 17
surveys and questionnaires (17) 17
adolescents (16) 16
combined modality therapy (16) 16
diagnosis (16) 16
endocrine therapy (16) 16
enzyme-linked immunosorbent assay (16) 16
follow-up studies (16) 16
genetic aspects (16) 16
life sciences (16) 16
paclitaxel (16) 16
patients (16) 16
risk (16) 16
survival analysis (16) 16
article (15) 15
breast neoplasms - chemistry (15) 15
chemistry, physical (15) 15
gene-expression (15) 15
lymph nodes - pathology (15) 15
pregnancy (15) 15
stress (15) 15
animal reproduction (14) 14
breast neoplasms - surgery (14) 14
breast neoplasms - therapy (14) 14
evolution (14) 14
medical research (14) 14
mortality (14) 14
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Positron Emission Tomography Using [18F]Fluorodeoxyglucose for Monitoring Primary Chemotherapy in Breast Cancer
by M. Schelling and N. Avril and J. Nährig and W. Kuhn and W. Römer and D. Sattler and M. Werner and J. Dose and F. Jänicke and H. Graeff and M. Schwaiger
Journal of Clinical Oncology, ISSN 0732-183X, 04/2000, Volume 18, Issue 8, pp. 1689 - 1695
Purpose: To address the role of positron emission tomography (PET) using [F-18]fluorodeoxyglucose (FDG) to monitor primary (neoadjuvant) chemotherapy in... 
WOMEN | PREOPERATIVE CHEMOTHERAPY | NEOADJUVANT CHEMOTHERAPY | GLUCOSE ANALOG | ONCOLOGY | PRIMARY TUMOR | PATHOLOGICAL RESPONSE | FLUORINE-18-FDG PET | F-18 2-DEOXY-2-FLUORO-D-GLUCOSE | CARCINOMA | AXILLARY LYMPH-NODES | Predictive Value of Tests | Cyclophosphamide - administration & dosage | Prospective Studies | Humans | Middle Aged | Carcinoma, Lobular - diagnostic imaging | Epirubicin - administration & dosage | Breast Neoplasms - drug therapy | Carcinoma, Ductal, Breast - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Sensitivity and Specificity | Adult | Female | Fluorodeoxyglucose F18 | ROC Curve | Carcinoma, Lobular - drug therapy | Tomography, Emission-Computed | Breast Neoplasms - diagnostic imaging | Paclitaxel - administration & dosage | Radiopharmaceuticals | Carcinoma, Ductal, Breast - diagnostic imaging
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
by Early Breast Cancer Trialists' Collaborative Group (EBCTCG) and EBCTCG and Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9793, pp. 771 - 784
Summary Background As trials of 5 years of tamoxifen in early breast cancer mature, the relevance of hormone receptor measurements (and other patient... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | POSTMENOPAUSAL | THERAPY | HIGH-RISK | DOXORUBICIN | RECURRENCE | PREMENOPAUSAL WOMEN | PROGESTERONE-RECEPTOR | ESTROGEN-RECEPTOR | CHEMOTHERAPY | IMMUNOHISTOCHEMISTRY | Receptors, Estrogen - metabolism | Neoplasm Recurrence, Local - prevention & control | Humans | Selective Estrogen Receptor Modulators - adverse effects | Breast Neoplasms - drug therapy | Breast Neoplasms - metabolism | Randomized Controlled Trials as Topic | Receptors, Progesterone - metabolism | Antineoplastic Agents, Hormonal - adverse effects | Selective Estrogen Receptor Modulators - therapeutic use | Breast Neoplasms - pathology | Neoplasms, Second Primary - chemically induced | Antineoplastic Agents, Hormonal - therapeutic use | Tamoxifen - therapeutic use | Breast Neoplasms - mortality | Female | Chemotherapy, Adjuvant | Tamoxifen - adverse effects | Patient outcomes | Breast cancer | Research | Diagnosis | Tamoxifen | Drug therapy | Health aspects | Chemotherapy | Compliance | Womens health | Mortality | Endocrine therapy | Data collection | Stratigraphy | Cancer therapies | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction With ST-Segment Elevation
by Sabatine, M.S and Cannon, C.P and Gibson, C.M and CLARITY-TIMI 28 Investigators
ACC Current Journal Review, ISSN 1062-1458, 2005, Volume 14, Issue 6, pp. 1 - 1
BACKGROUND: A substantial proportion of patients receiving fibrinolytic therapy for myocardial infarction with ST-segment elevation have inadequate reperfusion... 
MEDICINE, GENERAL & INTERNAL | DESIGN | PLASMINOGEN-ACTIVATOR | RATIONALE | TIMI | FOLLOW-UP | THROMBOLYSIS | REPERFUSION THERAPY | REOCCLUSION | HEPARIN | Usage | Thrombolytic drugs | Drug therapy | Heart attack | Prescription drugs | Heart attacks | Health risk assessment | Medical treatment
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Comment on "Empirical model derived from dispersion calculations to determine separation distances between livestock buildings and residential areas to avoid odour nuisance" by G. Schauberger, R. Schmitzer, M. Kamp, A. Sowa, R. Koch, W. Eckhof, F. Eichler, E. Grimm, J. Kypke, E. Hartung. Atmospheric Environment(2011)
by Janicke, Ulf and Müller, Wolfgang J and Both, Ralf and Trukenmüller, Alfred
Atmospheric Environment, ISSN 1352-2310, 04/2012, Volume 50, pp. 385 - 386
METEOROLOGY & ATMOSPHERIC SCIENCES | ENVIRONMENTAL SCIENCES | TURBULENCE
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Dual Regulation of Fbw7 Function and Oncogenic Transformation by Usp28
by Schülein-Völk, Christina and Wolf, Elmar and Zhu, Jing and Xu, Wenshan and Taranets, Lyudmyla and Hellmann, Andreas and Jänicke, Laura A and Diefenbacher, Markus E and Behrens, Axel and Eilers, Martin and Popov, Nikita
Cell Reports, ISSN 2211-1247, 11/2014, Volume 9, Issue 3, pp. 1099 - 1109
Fbw7, the substrate recognition subunit of SCF(Fbw7) ubiquitin ligase, mediates the turnover of multiple proto-oncoproteins and promotes its own degradation.... 
DEPENDENT PHOSPHORYLATION | SUBSTRATE DEGRADATION | P53-MDM2 PATHWAY | UBIQUITIN LIGASE | GROWTH | TUMOR-SUPPRESSOR | MYC PROTEIN STABILITY | DIFFERENTIATION | DNA-DAMAGE-RESPONSE | CANCER | CELL BIOLOGY | F-Box-WD Repeat-Containing Protein 7 | Biocatalysis | Cell Proliferation | F-Box Proteins - metabolism | Humans | Cell Cycle Proteins - metabolism | Ubiquitin-Protein Ligases - metabolism | Substrate Specificity | Organ Specificity | Cell Transformation, Neoplastic - metabolism | Mice, Knockout | Animals | Models, Biological | Proteolysis | Gene Deletion | Alleles | Ubiquitin Thiolesterase - metabolism | Transcription, Genetic | HeLa Cells | Protein Stability | Cell Transformation, Neoplastic - pathology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials
by Abe, O and Abe, R and Enomoto, K and Kikuchi, K and Koyama, H and Masuda, H and Nomura, Y and Sakai, K and Sugimachi, K and Tominaga, T and Uchino, J and Yoshida, M and Haybittle, J.L and Davies, C and Harvey, V.J and Holdaway, T.M and Kay, R.G and Mason, B.H and Forbes, J.F and Wilcken, N and Gnant, M and Jakesz, R and Ploner, M and Yosef, H.M.A and Focan, C and Lobelle, J.P and Peek, U and Oates, G.D and Powell, J and Durand, M and Mauriac, L and Di Leo, A and Dolci, S and Piccart, M.J and Masood, M.B and Parker, D and Price, J.J and Hupperets, P.S.G.J and Jackson, S and Ragaz, J and Berry, D and Broadwater, G and Cirrincione, C and Muss, H and Norton, L and Weiss, R.B and Abu-Zahra, H.T and Portnoj, S.M and Baum, M and Cuzick, J and Houghton, J and Riley, D and Mansel, R.E and Gordon, N.H and Davis, H.L and Beatrice, A and Mihura, J and Naja, A and Lehingue, Y and Romestaing, P and Dubois, J.B and Delozier, T and Mace Lesec'h, J and Rambert, P and Petruzelka, L and Pribylova, O and Owen, J.R and Harbeck, N and Jänicke, F and Meisner, C and Meier, P and Howell, A and Ribeiro, G.C and Swindell, R and Burrett, J and Clarke, M and Collins, R and Darby, S and Davies, C and Elphinstone, P and Evans, V and Godwin, J and Gray, R and Harwood, C and Hicks, C and Jackson, D and James, S and MacKinnon, E and McGale, P and McHugh, T and Mead, G and Morris, P and Oulds, J and Peto, R and Taylor, C and Wang, Y and Albano, J and De Oliveira, C.F and Gervásio, H and Gordilho, J and ... and Oxford CTSU and EBCTC and Early Breast Cancer Trialists' Collaborative Group (EBCTCG) and Medicinska fakulteten and Institutionen för strålningsvetenskaper and Onkologi and Umeå universitet
The Lancet, ISSN 0140-6736, 2005, Volume 366, Issue 9503, pp. 2087 - 2106
In early breast cancer, variations in local treatment that substantially affect the risk of locoregional recurrence could also affect long-term breast cancer... 
MEDICINE, GENERAL & INTERNAL | CARE PROCESS SURVEY | HEART-DISEASE | SURGICAL ADJUVANT BREAST | CONTRALATERAL BREAST | CONSERVING SURGERY | POSTOPERATIVE RADIOTHERAPY | LOCOREGIONAL RADIATION-THERAPY | PREMENOPAUSAL WOMEN | STAGE-I | TOTAL MASTECTOMY | Breast Neoplasms - surgery | Humans | Middle Aged | Probability | Cause of Death | Randomized Controlled Trials as Topic | Disease-Free Survival | Breast Neoplasms - radiotherapy | Time Factors | Breast Neoplasms - mortality | Female | Aged | Neoplasm Recurrence, Local - epidemiology | Evaluation | Complications and side effects | Care and treatment | Patient outcomes | Breast cancer | Radiotherapy | Cancer | Relapse | Surgery | Breast | Health aspects | Risk factors | Diseases | Therapy | Side effects | Mortality | Radiology | Health risk assessment | care process survey | heart-disease | stage-1 | postoperative radiotherapy | contralateral breast | premenopausal women | Locoregional radiation therapy | surgical adjuvant breast | total mastectomy | conserving surgery
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Early prediction of response to chemotherapy in metastatic breast cancer using sequential18F-FDG PET
by Schwarz, Joerg Dose and Bader, Michael and Jenicke, Lars and Hemminger, Gabriele and Jänicke, Fritz and Avril, Norbert
Journal of Nuclear Medicine, ISSN 0161-5505, 2005, Volume 46, Issue 7, pp. 1144 - 1150
Breast cancer | Prediction of response to therapy | F-FDG | PET | Metastases
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
by Abe, O and Abe, R and Enomoto, K and Kikuchi, K and Koyama, H and Masuda, H and Nomura, Y and Sakai, K and Sugimachi, K and Tominaga, T and Uchino, J and Yoshida, M and Haybittle, JL and Davies, C and Harvey, VJ and Holdaway, TM and Kay, RG and Mason, BH and Forbes, JF and Wilcken, N and Gnant, M and Jakesz, R and Ploner, M and Yosef, HMA and Focan, C and Lobelle, JP and Peek, U and Oates, GD and Powell, J and Durand, M and Mauriac, L and Di Leo, A and Dolci, S and Piccart, MJ and Masood, MB and Parker, D and Price, JJ and Hupperets, PSGJ and Jackson, S and Ragaz, J and Berry, D and Dubois, JB and Gray, R and de Vries, EGE and Klijn, JGM and Kaufmann, M and Zhao, DB and Nilsson, J and Buchanan, RB and EBCTCG and Early Breast Cancer Trialists' Collaborative Group (EBCTCG) and Onkologi och Patologi, MV and Lund University and Oncology and Pathology, MV and Sektion V and Division V and Institutionen för kliniska vetenskaper, Malmö and Lunds universitet and Department of Clinical Sciences, Malmö
The Lancet, ISSN 0140-6736, 2005, Volume 365, Issue 9472, pp. 1687 - 1717
Quinquennial overviews (1985–2000) of the randomised trials in early breast cancer have assessed the 5 year and 10-year effects of various systemic adjuvant... 
UMCG Approved | TAMOXIFEN | DEATHS | MEDICINE, GENERAL & INTERNAL | Ovariectomy | Humans | Middle Aged | Neoplasm Recurrence, Local | Survival Rate | Receptors, Estrogen - analysis | Breast Neoplasms - drug therapy | Cause of Death | Randomized Controlled Trials as Topic | Breast Neoplasms - therapy | Neoplasm Metastasis | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Antineoplastic Agents, Hormonal - therapeutic use | Tamoxifen - therapeutic use | Breast Neoplasms - mortality | Female | Ovary - drug effects | Aged | Anthracyclines - therapeutic use | Chemotherapy, Adjuvant | Chemotherapy | Breast cancer | Diagnosis | Research | Drug therapy | Health aspects | Cancer | Clinical trials | Prescription drugs | Hormone replacement therapy | Mortality | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights